The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Marie von Lilienfeld-Toal

Transplant Immunology Group

Level 3

St. James's Institute of Oncology

Bexley Wing

UK

[email]@uni-bonn.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Transplant Immunology Group, Level 3, St. James's Institute of Oncology, Bexley Wing, UK. 2010
  • Med. Klinik und Poliklinik III, Universitätsklinikum Bonn, Germany. 2009
  • Medizinische Klinik und Poliklinik III, Rheinische Friedrich Wilhelms Universität, Germany. 2008
  • Medizinische Klinik und Poliklinik I, Universitätsklinikum Bonn, Sigmund-Freud Str. 25, 53105 Bonn. 2004 - 2007
  • Department of Medicine, Bonn University, Germany. 2005

References

  1. Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked. von Lilienfeld-Toal, M., Frank, S., Leyendecker, C., Feyler, S., Jarmin, S., Morgan, R., Glasmacher, A., Märten, A., Schmidt-Wolf, I.G., Brossart, P., Cook, G. Cancer Immunol. Immunother. (2010) [Pubmed]
  2. Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia. von Lilienfeld-Toal, M., Lehmann, L.E., Raadts, A.D., Hahn-Ast, C., Orlopp, K.S., Marklein, G., Purr, I., Cook, G., Hoeft, A., Glasmacher, A., Stüber, F. J. Clin. Microbiol. (2009) [Pubmed]
  3. A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in patients with relapsed or refractory multiple myeloma. von Lilienfeld-Toal, M., Hahn-Ast, C., Furkert, K., Hoffmann, F., Naumann, R., Bargou, R., Cook, G., Glasmacher, A. Eur. J. Haematol. (2008) [Pubmed]
  4. A randomized comparison of immediate versus delayed application of G-CSF in induction therapy for patients with acute myeloid leukemia unfit for intensive chemotherapy. von Lilienfeld-Toal, M., Hahn-Ast, C., Kirchner, H., Flieger, D., Dölken, G., Glasmacher, A. Haematologica (2007) [Pubmed]
  5. Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies. von Lilienfeld-Toal, M., Schneider, A., Orlopp, K., Hahn-Ast, C., Glasmacher, A., Stüber, F. Support. Care. Cancer (2006) [Pubmed]
  6. Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells. von Lilienfeld-Toal, M., Nattermann, J., Feldmann, G., Sievers, E., Frank, S., Strehl, J., Schmidt-Wolf, I.G. Clin. Exp. Immunol. (2006) [Pubmed]
  7. Coculture with dendritic cells promotes proliferation but not cytotoxic activity of gamma/delta T cells. von Lilienfeld-Toal, M., Sievers, E., Bodemüller, V., Mihailescu, C., Märten, A., Gorschlüter, M., Schmidt-Wolf, I.G. Immunol. Lett. (2005) [Pubmed]
  8. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. von Lilienfeld-Toal, M., Dietrich, M.P., Glasmacher, A., Lehmann, L., Breig, P., Hahn, C., Schmidt-Wolf, I.G., Marklein, G., Schroeder, S., Stuber, F. Eur. J. Clin. Microbiol. Infect. Dis. (2004) [Pubmed]
 
WikiGenes - Universities